93 related articles for article (PubMed ID: 24530506)
1. Phosphorylation of p300 increases its protein degradation to enhance the lung cancer progression.
Wang SA; Hung CY; Chuang JY; Chang WC; Hsu TI; Hung JJ
Biochim Biophys Acta; 2014 Jun; 1843(6):1135-49. PubMed ID: 24530506
[TBL] [Abstract][Full Text] [Related]
2. A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer.
Paladino D; Yue P; Furuya H; Acoba J; Rosser CJ; Turkson J
Oncotarget; 2016 Feb; 7(6):7253-67. PubMed ID: 26695438
[TBL] [Abstract][Full Text] [Related]
3. Akt SUMOylation regulates cell proliferation and tumorigenesis.
Li R; Wei J; Jiang C; Liu D; Deng L; Zhang K; Wang P
Cancer Res; 2013 Sep; 73(18):5742-53. PubMed ID: 23884910
[TBL] [Abstract][Full Text] [Related]
4. Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression.
Chen PM; Wu TC; Wang YC; Cheng YW; Sheu GT; Chen CY; Lee H
Carcinogenesis; 2013 Nov; 34(11):2655-63. PubMed ID: 23784082
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of EBAF in the heart with ventricular septal defects and its regulation by histone acetyltransferase p300 and transcription factors smad2 and cited2.
Su D; Li Q; Guan L; Gao X; Zhang H; Dandan E; Zhang L; Ma X
Biochim Biophys Acta; 2013 Dec; 1832(12):2145-52. PubMed ID: 23899608
[TBL] [Abstract][Full Text] [Related]
6. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
Yoon H; Lim JH; Cho CH; Huang LE; Park JW
Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
[TBL] [Abstract][Full Text] [Related]
7. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M
Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137
[TBL] [Abstract][Full Text] [Related]
8. De-acetylation and degradation of HSPA5 is critical for E1A metastasis suppression in breast cancer cells.
Chang YW; Chen HA; Tseng CF; Hong CC; Ma JT; Hung MC; Wu CH; Huang MT; Su JL
Oncotarget; 2014 Nov; 5(21):10558-70. PubMed ID: 25301734
[TBL] [Abstract][Full Text] [Related]
9. Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf-Hirschhorn syndrome candidate 1/Twist pathway.
Kuo CH; Chen KF; Chou SH; Huang YF; Wu CY; Cheng DE; Chen YW; Yang CJ; Hung JY; Huang MS
Carcinogenesis; 2013 Nov; 34(11):2600-9. PubMed ID: 23955539
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
Li X; Wan L; Geng J; Wu CL; Bai X
J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
[TBL] [Abstract][Full Text] [Related]
11. nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition.
Zhao R; Gong L; Li L; Guo L; Zhu D; Wu Z; Zhou Q
Exp Cell Res; 2013 Mar; 319(5):740-9. PubMed ID: 23137649
[TBL] [Abstract][Full Text] [Related]
12. p190A RhoGAP is involved in EGFR pathways and promotes proliferation, invasion and migration in lung adenocarcinoma cells.
Notsuda H; Sakurada A; Endo C; Okada Y; Horii A; Shima H; Kondo T
Int J Oncol; 2013 Nov; 43(5):1569-77. PubMed ID: 24043274
[TBL] [Abstract][Full Text] [Related]
13. WT1 promotes invasion of NSCLC via suppression of CDH1.
Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y
J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling?
Shen Z; Chen L; Yang X; Zhao Y; Pier E; Zhang X; Yang X; Xiong Y
Biochim Biophys Acta; 2013 Oct; 1833(10):2190-200. PubMed ID: 23688634
[TBL] [Abstract][Full Text] [Related]
15. SOX9 inhibits β-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties.
Deng W; Vanderbilt DB; Lin CC; Martin KH; Brundage KM; Ruppert JM
J Cell Sci; 2015 Mar; 128(6):1123-38. PubMed ID: 25632159
[TBL] [Abstract][Full Text] [Related]
16. HTLV-1 bZIP factor impedes the menin tumor suppressor and upregulates JunD-mediated transcription of the hTERT gene.
Borowiak M; Kuhlmann AS; Girard S; Gazzolo L; Mesnard JM; Jalinot P; Dodon MD
Carcinogenesis; 2013 Nov; 34(11):2664-72. PubMed ID: 23784080
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH
Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662
[TBL] [Abstract][Full Text] [Related]
18. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas.
Ishihama K; Yamakawa M; Semba S; Takeda H; Kawata S; Kimura S; Kimura W
J Clin Pathol; 2007 Nov; 60(11):1205-10. PubMed ID: 17720775
[TBL] [Abstract][Full Text] [Related]
19. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
Jeannot V; Busser B; Brambilla E; Wislez M; Robin B; Cadranel J; Coll JL; Hurbin A
Int J Cancer; 2014 Jun; 134(11):2560-71. PubMed ID: 24374738
[TBL] [Abstract][Full Text] [Related]
20. Sirt3 is a tumor suppressor in lung adenocarcinoma cells.
Xiao K; Jiang J; Wang W; Cao S; Zhu L; Zeng H; Ouyang R; Zhou R; Chen P
Oncol Rep; 2013 Sep; 30(3):1323-8. PubMed ID: 23842789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]